Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia
Clinical trial NCT01444716 · COMPLETED
Trial details
- NCT number
- NCT01444716
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-15
- Primary completion
- 2020-06-11
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.